Establishment of patient-derived organoid models of lower-grade glioma
Source Abdullah et al., 2022 · University of Texas Southwestern Medical Center · 10.1093/neuonc/noab273
Abstract
This protocol describes an optimized method for establishing patient-derived organoid models from lower-grade glioma (LGG) primary tumor tissue samples using physiologic 5% oxygen conditions. The resulting organoids recapitulate parental tumor characteristics including cytoarchitecture, cellular heterogeneity, proliferative capacity, and genomic alterations, providing a faithful in vitro platform for preclinical studies of LGG biology and treatment response assessment.
Protocol overview
15 steps across 4 phases
- 1 Tumor tissue collection and transport
- 2 Red blood cell lysis
- 3 Tissue washing
- 4 Tissue dissection
- 5 Organoid plating
- 6 Incubation setup
- 7 Medium refreshment
- 8 Culture duration and monitoring
- 9 Organoid grouping for freezing
- 10 DMSO addition and cryotube preparation
- 11 Controlled-rate freezing
- 12 Long-term storage in liquid nitrogen
- 13 Reanimation after biobanking
- 14 Organoid fixation
- 15 Formalin removal and ethanol preservation
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Abdullah et al., 2022. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol